Genomic profiling and expanded use of targeted anticancer drugs in solid cancers with exhausted evidence-based treatment options (PRECODE): study protocol of a prospective, non-randomized, cohort study
Authors
Henrik Petersen (ORCID: https://orcid.org/0000-0002-1118-1500)
Lotte Krogh
Henrik J. Ditzel (ORCID: https://orcid.org/0000-0003-3927-5135)
Genomic profiling and expanded use of targeted anticancer drugs in solid cancers with exhausted evidence-based treatment options (PRECODE): study protocol of a prospective, non-randomized, cohort study
Henrik Petersen, Lotte Krogh, Henrik J. Ditzel, Sidse Ehmsen et al.
Journal
BMC Medical Genomics
Topics
Cancer Genomics and Diagnostics
article
Genomic profiling and expanded use of targeted anticancer drugs in solid cancers with exhausted evidence-based treatment options (PRECODE): study protocol of a prospective, non-randomized, cohort study
Henrik Petersen, Lotte Krogh, Henrik J. Ditzel, Sidse Ehmsen, Thomas Kielsgaard Kristensen, Karin Holmskov Hansen, Arman Arshad, Jon Thor Asmussen, Annette Raskov Kodahl, Maria Lyng
article en
Abstract
No abstract available for this paper.
Publication Tag
BMC Medical GenomicsVol. 17(1)
Institutions
University of Southern Denmark (DK), Odense University Hospital (DK)